Oct. 16, 2012News & Opinions
Swiss drugmaker Roche Holding is banking on a new generation of breast cancer medicines to drive sales growth after strong demand for its established cancer treatments helped it to top forecasts in the third quarter.
Apr. 04, 2012News & Opinions
Roche stepped up pressure on Illumina shareholders in its battle to take over the U.S. gene sequencing company, telling them in a letter that its increased $6.7 billion bid represented concrete value in a high-risk market.
The latest information directly via newsletter.